+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Devices Market - Global Forecast 2026-2032- Product Image
Cardiovascular Devices Market - Global Forecast 2026-2032- Product Image
Sale

Cardiovascular Devices Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336858
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Devices Market is projected to reach USD 68.69 Billion in 2026. It is expected to continue growing at a CAGR of 8.06%, reaching USD 109.79 Billion by 2032.

Cardiovascular devices remain central to modern care because cardiovascular disease is the world’s leading cause of death. The World Health Organization estimates that cardiovascular diseases account for approximately 17.9 million deaths each year, while the CDC reports that heart disease is the leading cause of death in the United States. This sustained clinical burden is driving demand for diagnostic, interventional, surgical, rhythm management, structural heart, vascular access, hemodynamic support, and remote cardiac monitoring technologies.

The cardiovascular devices market is being shaped by aging populations, rising hypertension, obesity, and diabetes prevalence, earlier diagnosis, and the shift from open procedures to minimally invasive and catheter-based cardiovascular interventions. Hospitals, ambulatory surgical centers, cardiac catheterization laboratories, and connected-care programs are prioritizing medical devices that shorten length of stay, reduce readmissions, improve procedural precision, support guideline-based care, and generate clinically useful data across the patient journey.

Transformative Shifts in the Cardiovascular Devices Landscape

The cardiovascular devices landscape is moving from episodic intervention toward integrated, data-enabled cardiovascular care. Structural heart devices, drug-eluting stents, transcatheter valve systems, electrophysiology tools, cardiac rhythm management devices, ventricular assist devices, vascular closure devices, and wearable cardiac monitors are increasingly evaluated not only on procedural success but also on total cost of care, patient safety, and long-term clinical outcomes.

Regulatory and reimbursement expectations are also transforming the sector. The U.S. FDA’s continued emphasis on real-world evidence, the European Union Medical Device Regulation’s stricter clinical evidence requirements, and growing payer scrutiny are raising the bar for safety, traceability, post-market surveillance, cybersecurity, and health economic value. As a result, manufacturers are investing in clinical differentiation, resilient supply chains, software validation, human factors engineering, and lifecycle evidence generation.

Cumulative Impact of Artificial Intelligence on Cardiovascular Devices

Artificial intelligence is creating cumulative value across cardiovascular devices by improving signal interpretation, imaging workflows, risk stratification, triage, and remote patient monitoring. FDA-cleared AI-enabled medical technologies have expanded rapidly in recent years, with cardiovascular applications represented across ECG analytics, echocardiography support, CT-based assessment, arrhythmia detection, coronary imaging, and clinical decision support.

The most important impact is not a single algorithm but the compounding effect of AI across cardiovascular device ecosystems. AI can help detect atrial fibrillation earlier, prioritize high-risk patients, automate measurements, reduce operator variability, support continuous monitoring after discharge, and improve workflow efficiency in high-volume cardiac settings. However, adoption depends on validated performance across diverse populations, transparent model governance, cybersecurity controls, interoperability with clinical systems, workflow integration, and reimbursement pathways that reward measurable clinical benefit.

Key Regional Insights for Cardiovascular Devices

Asia-Pacific is a high-opportunity cardiovascular devices region due to large patient populations, expanding insurance coverage, rising noncommunicable disease burden, and rapid hospital infrastructure development across China, India, Japan, South Korea, Australia, and Southeast Asia. Japan and Australia remain mature, quality-driven markets with strong clinical governance, while China and India are scaling domestic manufacturing, catheterization capacity, cardiac surgery access, and interventional cardiology services. Southeast Asian health systems are also expanding cardiac care capabilities through public investment, private hospital growth, and medical tourism-oriented centers of excellence.

North America continues to lead in premium cardiovascular device adoption, clinical trials, digital health integration, and early commercialization, supported by advanced electrophysiology, structural heart, heart failure management, and remote monitoring programs. Europe remains a major innovation and regulatory hub, although compliance with EU MDR is reshaping product portfolios, documentation requirements, and clinical evidence strategies. Latin America shows growing demand in Brazil and Mexico but remains influenced by public procurement cycles, reimbursement variability, and uneven access to specialized cardiac services. The Middle East, especially GCC health systems, is investing in tertiary cardiac care, digital hospitals, and specialist workforce capacity, while Africa presents long-term access opportunities tied to infrastructure investment, workforce development, affordable device models, and stronger referral networks for cardiovascular disease management.

Key Group Insights Across Strategic Market Blocs

ASEAN is emerging as an important growth corridor as Indonesia, Vietnam, Thailand, Malaysia, Singapore, and the Philippines expand cardiac care capacity, private hospital networks, and access to interventional procedures. Singapore acts as a regional clinical, training, and distribution hub, while larger ASEAN markets are focused on affordability, public-private partnerships, localized service networks, and improved access to diagnostic and therapeutic cardiovascular devices.

The GCC is investing heavily in specialty cardiovascular centers, digital health infrastructure, and premium medical technologies aligned with national health transformation programs. The European Union is defined by strong clinical standards, centralized regulatory obligations under EU MDR, health technology assessment scrutiny, and demand for evidence-backed cardiovascular innovation. BRICS economies combine significant cardiovascular disease burden with manufacturing scale, public procurement influence, and pricing pressure, creating opportunities for value-engineered devices and localized production. G7 markets remain benchmarks for advanced adoption, reimbursement evidence, clinical guideline influence, and premium innovation, while NATO-aligned healthcare and procurement environments increasingly emphasize supply chain resilience, cybersecurity, device traceability, and trusted medical technology sourcing.

Key Country Insights in Cardiovascular Devices

The United States is a major innovation and commercialization platform for cardiovascular devices, supported by high procedure volumes, FDA regulatory pathways, Medicare coverage influence, and strong adoption of rhythm management, structural heart, electrophysiology, ambulatory diagnostics, and remote monitoring technologies. Canada offers a publicly funded, evidence-driven environment with emphasis on clinical value and equitable access, while Mexico combines private hospital demand with proximity to North American manufacturing and supply networks. Brazil is Latin America’s largest cardiovascular care opportunity by population scale, driven by expanding interventional cardiology and hospital modernization, although reimbursement complexity and public procurement variability remain important considerations.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are major cardiovascular care markets with strong specialist networks, guideline-based treatment pathways, and established hospital systems, with Germany standing out for hospital infrastructure and procedural capacity. Russia has demand for advanced cardiac technologies but faces procurement, sanctions, localization, and supply chain constraints. China is scaling domestic innovation, local procurement, and high-volume cardiovascular intervention capacity; India is expanding access through affordability-focused care models and growing tertiary hospitals; Japan emphasizes quality, safety, and aging-related cardiovascular care; Australia supports high-standard clinical adoption within a regulated health system; and South Korea combines advanced hospitals with strong medical technology, digital health capability, and rapid adoption of connected cardiovascular care.

Actionable Recommendations for Cardiovascular Device Leaders

Industry leaders should prioritize differentiated clinical evidence rather than incremental feature claims. Cardiovascular devices that demonstrate reduced complications, shorter hospitalization, better adherence, lower readmissions, improved procedural efficiency, or improved long-term outcomes are better positioned with providers, payers, and clinical decision-makers.

Executives should build AI governance, cybersecurity, interoperability, usability testing, and post-market surveillance into product strategy from the start. Companies should also diversify manufacturing, strengthen regional distribution and service partnerships, design value-tiered cardiovascular device portfolios for emerging markets, and align market access teams with real-world evidence generation. In high-priority categories such as structural heart, electrophysiology, heart failure monitoring, vascular intervention, and ambulatory cardiac diagnostics, partnerships with hospitals, digital health platforms, academic centers, and contract manufacturers can improve speed, scalability, and clinical relevance.

Research Methodology

This executive summary applies a structured secondary and analytical research methodology aligned with established market intelligence practices. Inputs include publicly available data from authoritative sources such as the WHO, CDC, FDA, OECD, Eurostat, national health agencies, regulatory databases, clinical guidelines, peer-reviewed literature, hospital and payer publications, and public medical technology disclosures.

The analysis triangulates cardiovascular disease burden, procedure adoption, regulatory changes, reimbursement dynamics, technology trends, AI adoption patterns, and regional market conditions. Qualitative interpretation is used to assess adoption barriers, investment priorities, clinical evidence expectations, and strategic positioning, while avoiding unsupported market sizing, market share, or forecasting claims. Insights are validated through consistency checks across clinical, regulatory, economic, and operational evidence sources.

Conclusion

The cardiovascular devices market is entering a more connected, evidence-intensive era. Demand is supported by the persistent global burden of cardiovascular disease, aging populations, and the clinical shift toward minimally invasive intervention, continuous monitoring, AI-enabled diagnostics, and personalized cardiovascular care.

Winners will be organizations that combine clinically meaningful innovation with regulatory discipline, AI-enabled intelligence, robust cybersecurity, interoperable data systems, and scalable access models. As providers and payers focus on outcomes, cardiovascular device manufacturers must prove value across the full care pathway, from diagnosis and intervention to recovery, monitoring, and long-term disease management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cardiovascular Devices Market, by Device Type
7.1. Introduction
7.2. Diagnostic & Monitoring Devices
7.2.1. ECG Systems
7.2.2. Electrode Leads & Accessories
7.2.3. Event Monitors
7.2.4. Holter Monitors
7.2.5. Implantable Loop Recorders
7.3. Surgical Devices
7.3.1. Cardiac Stents
7.3.2. Catheters
7.3.3. Heart Valves
7.3.4. Vascular Grafts
7.4. Therapeutic Devices
7.4.1. Blood Pressure Monitors
7.4.2. Defibrillators
7.4.3. Pacemakers
8. Cardiovascular Devices Market, by Access Type
8.1. Introduction
8.2. Transcutaneous
8.3. Transvenous
9. Cardiovascular Devices Market, by Procedure Type
9.1. Introduction
9.2. Interventional Cardiology Procedures
9.3. Electrophysiology Procedures
9.4. Cardiac Surgery
9.5. Structural Heart Procedures
10. Cardiovascular Devices Market, by Material Type
10.1. Introduction
10.2. Metal-based Devices
10.3. Polymer-based Devices
10.4. Bioresorbable Materials
11. Cardiovascular Devices Market, by Application
11.1. Introduction
11.2. Cardiac Rhythm Management
11.3. Coronary Artery Disease
11.4. Peripheral Vascular Disease
11.5. Stroke Management
12. Cardiovascular Devices Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Care
12.4. Hospitals & Clinics
13. Cardiovascular Devices Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Cardiovascular Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cardiovascular Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. ACS Diagnostics
17.3. Alivecor, Inc.
17.4. Asahi Kasei Corporation
17.5. B. Braun SE
17.6. Baxter International Inc.
17.7. Bexen Medical
17.8. Biotronik SE & Co KG
17.9. Boston Scientific Corporation
17.10. BPL Medical Technologies Private Limited
17.11. Edwards Lifesciences Corporation
17.12. GE Healthcare
17.13. HeartFlow Holding, Inc.
17.14. Johnson & Johnson Services, Inc.
17.15. Koninklijke Philips N.V.,
17.16. Lepu Medical Technology(Beijing)Co.,Ltd.
17.17. LivaNova PLC
17.18. Medtronic PLC
17.19. Microport Scientific Corporation
17.20. Nihon Kohden Corporation
17.21. Schiller AG
17.22. Siemens Healthineers
17.23. Terumo Cardiovascular Systems Corporation
17.24. Tricog Health
17.25. Vesalius Cardiovascular Inc.
17.26. Zoll Medical Corporation
List of Figures
FIGURE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ECG SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ECG SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ECG SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ELECTRODE LEADS & ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ELECTRODE LEADS & ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ELECTRODE LEADS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL EVENT MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL EVENT MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL EVENT MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HOLTER MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HOLTER MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HOLTER MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CARDIAC STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CARDIAC STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CARDIAC STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD PRESSURE MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL INTERVENTIONAL CARDIOLOGY PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL INTERVENTIONAL CARDIOLOGY PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL INTERVENTIONAL CARDIOLOGY PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ELECTROPHYSIOLOGY PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ELECTROPHYSIOLOGY PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ELECTROPHYSIOLOGY PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIAC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIAC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIAC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STRUCTURAL HEART PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL STRUCTURAL HEART PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL STRUCTURAL HEART PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL METAL-BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POLYMER-BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BIORESORBABLE MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BIORESORBABLE MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL BIORESORBABLE MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL STROKE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL STROKE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL STROKE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 135. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 136. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 137. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 138. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 139. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 140. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 155. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 156. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 157. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 158. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 160. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 161. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 166. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 167. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 168. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 169. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 170. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 171. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 172. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 176. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 177. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 178. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 179. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 180. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 181. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 182. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 196. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 197. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 198. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 199. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 200. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 201. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 202. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 206. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 207. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 208. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 209. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 210. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 211. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 212. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 216. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 217. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 218. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 219. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 220. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 221. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 222. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 236. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 237. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 238. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 239. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 240. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 241. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 242. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 243. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 247. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 248. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 249. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 250. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 251. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 252. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 253. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 277. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 278. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 279. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 280. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 281. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 282. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 283. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 287. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 288. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 289. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 290. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 291. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 292. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 307. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 308. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 309. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 310. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 311. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 312. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 313. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 314. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 317. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 318. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 319. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 320. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 321. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 322. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 323. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 327. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 328. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 329. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 330. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 331. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 332. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 333. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 337. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 338. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)
TABLE 339. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 340. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2017-2032 (USD MILLION)
TABLE 341. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 342. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 343. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 346. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 347. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 348. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2017-2032 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 68.69 Billion
Forecasted Market Value ( USD ) by 2032 $ 109.79 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

United States Cardiovascular Devices Market Report by Device Type, Application, End User, States and Company Analysis 2026-2034 - Product Image

United States Cardiovascular Devices Market Report by Device Type, Application, End User, States and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • United States
From
Middle East Cardiovascular Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Middle East Cardiovascular Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 95 Pages
  • Middle East
From
Cardiovascular Devices - Global Strategic Business Report - Product Image

Cardiovascular Devices - Global Strategic Business Report

  • Report
  • 311 Pages
  • Global
From
Cardiovascular Anastomosis Devices Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Anastomosis Devices Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Cardiovascular Catheters Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Catheters Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From

About the Cardiovascular Devices Market

The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth. Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.